CORD-19:29b6131c0d572d383cbc6774b12e4471aa612b07 / 11513-11786 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T69","span":{"begin":0,"end":273},"obj":"Sentence"},{"id":"T60233","span":{"begin":0,"end":273},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"One hundred plaque-forming units (pfu) of either icSARS-CoV or icGDO3-S were treated with heat-inactivated serum diluted to final concentrations of 1:100, 1:200, 1:400, 1:800, or 1:1,600 and incubated at 37 8C for 30 min, and the resulting titer determined by plaque assay."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T5","span":{"begin":107,"end":112},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"One hundred plaque-forming units (pfu) of either icSARS-CoV or icGDO3-S were treated with heat-inactivated serum diluted to final concentrations of 1:100, 1:200, 1:400, 1:800, or 1:1,600 and incubated at 37 8C for 30 min, and the resulting titer determined by plaque assay."}